首页> 外文OA文献 >PRS25 THE IMPACT TRIAL: IS SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) COST-EFFECTIVE VERSUS DUAL THERAPY WITH INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST (FF/VI) IN PATIENTS WITH COPD IN SPAIN?

【2h】

PRS25 THE IMPACT TRIAL: IS SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) COST-EFFECTIVE VERSUS DUAL THERAPY WITH INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST (FF/VI) IN PATIENTS WITH COPD IN SPAIN?

机译：PRS25的影响试验：单吸入器三重治疗（FF / UMEC / VI）与吸入皮质类固醇加上双重治疗是否有重复的皮质类固醇加上西班牙患者的长效β激动剂（FF / VI）？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
V. Paly; L.A. Vallejo-Aparicio; M. Schroeder; A. Martin; J.L. Izquierdo Alonso; J.A. Riesco Miranda; J.J. Soler Cataluña; N. Risebrough; C. Abreu; C. Biswas; A.S. Ismaila;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. INFORMING THE PATHWAY OF COPD TREATMENT (THE IMPACT STUDY): SINGLE INHALER TRIPLE THERAPY (FF/UMEC/ VI) VERSUS DUAL BRONCHODILATOR THERAPY (UMEC/ VI) IN PATIENTS WITH COPD - COST-EFFECTIVENESS IN THE UK [J] . Anley G., Shah D., Schroeder M., Thorax: The Journal of the British Thoracic Society . 2018,第Suppla4期

机译：通知COPD治疗的途径（影响研究）：在英国COPD - 成本效益的患者中，单次吸入器三重治疗（FF / UMEC / VI）与双支气管扩张剂治疗（UMEC / VI）
2. Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses [J] . Mario Cazzola, Luigino Calzetta, Paola Rogliani, Pulmonary therapy. . 2019,第2期

机译：Triple治疗与双支气管扩张和吸入皮质类固醇/长效β-激动剂在COPD中：从网络META分析中累积证据
3. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta(2)-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial [J] . Singh Dave, Papi Alberto, Corradi Massimo, The Lancet . 2016,第10048期

机译：单吸入器三联疗法与吸入性糖皮质激素加长效β（2）激动剂治疗慢性阻塞性肺疾病（TRILOGY）：双盲，平行组，随机对照试验
4. Impact of Complementary Therapies via Mobile Technologies on Icelandic Same Day Surgical Patients' Reports of Anxiety, Pain and Self-Efficacy in Healing: A Randomized Controlled Trial in Process [C] . Margaret M. Hansen MEDINFO . 2013

机译：互补疗法通过移动技术对冰岛同日外科患者的影响焦虑，痛苦和自我疗效愈合中的报告：过程中的随机对照试验
5. Addition of leukotriene receptor antagonists versus long acting beta agonists to inhaled corticosteroid therapy for asthma treatment in older adults: A retrospective data analysis of effectiveness, safety and cost. [D] . Altawalbeh, Shoroq Mahmoud. 2015

机译：在吸入性糖皮质激素治疗中，将白三烯受体拮抗剂与长效β激动剂相比，用于老年人的哮喘治疗：有效性，安全性和成本的回顾性数据分析。
6. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial [O] . Jinping Zheng, Simonetta Baldi, Li Zhao, 2021

机译：单吸入器外列三重治疗的疗效和安全性与吸入皮质类固醇加上东亚患者的长效β2激动剂：Triversyti随机对照试验
7. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial [O] . Jinping Zheng, Simonetta Baldi, Li Zhao, 2021

机译：单吸入器外列三重治疗的疗效和安全性与吸入皮质类固醇加上东亚患者的长效β2激动剂：Triversyti随机对照试验
8. Comparison of Health Care Utilization and Costs Associated With Inhaled Corticosteroid Versus Beta(2)-Agonist Therapy in the Management of Asthma at Darnall Army Community Hospital [R] . Bui, T. P. 2000

机译：在Darnall陆军社区医院治疗哮喘的医疗保健利用和与吸入皮质类固醇相关的成本比较（2） - agonist疗法

PRS25 THE IMPACT TRIAL: IS SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) COST-EFFECTIVE VERSUS DUAL THERAPY WITH INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST (FF/VI) IN PATIENTS WITH COPD IN SPAIN?

著录项

引文网络

相似文献

相关主题

期刊订阅